People with relapsing-remitting multiple sclerosis (RRMS) who show even a single silent lesion on an MRI scan while taking…
Michela Luciano, PhD
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in acute myeloid leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as Scientific Writer in 2022. Outside of work she enjoys street photogtaphy, mountain hikes, running, and spending as much time as possible outdoors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Michela Luciano, PhD
Certain cannabis-based therapies may provide relief from spasticity in people with multiple sclerosis (MS), according to a review of…
Following the submission of thousands of pages of documentation, the U.S. Food and Drug Administration (FDA) has given the green…
Smoking cigarettes may speed up disease progression in people with multiple sclerosis (MS), while alcohol consumption showed no clear…
Following a Mediterranean-style diet may be associated with lower odds of multiple sclerosis (MS) onset, and diet-related differences in…
Certain diets may support cognitive function in people with multiple sclerosis (MS), according to a systematic review of available studies.
Physical exercise may do more than improve muscle strength and mobility in people with multiple sclerosis (MS): Certain types…
A research team at the University of California, Los Angeles (UCLA) has received a $7.49 million grant to advance a…
Measles-mumps-rubella (MMR) and chickenpox (varicella) vaccines do not increase the risk of relapse for people with multiple sclerosis (MS), according…
The U.S. Food and Drug Administration (FDA) has given Pheno Therapeutics the green light to begin clinical testing of…
An artificial intelligence (AI) model that analyzes brain scans alongside clinical and demographic data showed high accuracy in predicting which…
The number of people living with multiple sclerosis (MS) has risen steadily over the past two decades, but the…
A new formulation of Briumvi (ublituximab) — TG Therapeutics’ therapy for relapsing forms of multiple sclerosis (MS) — designed…
Higher consumption of ultra-processed foods, such as soft drinks, packaged snacks, and ready-to-eat meals, may be associated with an increased…
The presence of multiple asymptomatic spinal cord lesions — areas of damage, as captured by imaging scans — is associated…
Liberate Bio’s investigational CAR-M cell therapy LIB820 may help successfully eliminate disease-driving B-cells in autoimmune diseases such as…
Menstrual fluid collected from tampons could one day provide a simple, noninvasive way to measure a biomarker of nerve damage…
A new formulation — a film that dissolves under the tongue — of cladribine for treating multiple sclerosis (MS)…
People with diabetes are significantly more likely — with nearly 60% higher odds — to develop multiple sclerosis (MS)…
Urinary issues are a frequent and distressing reality for women with multiple sclerosis (MS), and new research suggests these…
A 12-week intervention combining breathing exercises, cold exposure, and meditation — known as the Wim Hof Method (WHM) — or…
Quantum Biopharma is preparing to seek permission in the U.S. to launch its planned clinical trial of Lucid-MS,…
Brain atrophy, or the loss of brain volume, in people with relapsing-remitting multiple sclerosis (RRMS) appears to slow with…
Ludwig Kappos, MD, a neurologist and researcher at University Hospital in Basel, Switzerland, has been named the 2026 recipient of…
Loss of brain volume (brain atrophy), a measure often used in clinical trials to track disease progression, may not accurately…
Low to moderate doses of vitamin D supplements may be linked to lower relapse rates in people with multiple…
Breastfeeding for longer during infancy may delay the onset of multiple sclerosis (MS) and slow its progression for people…
AB Science has received a patent in Japan covering the use of its investigational oral therapy masitinib for progressive…
Paralyzed Veterans of America (PVA) — a congressionally chartered veterans organization open to all military service members with…
A greater intake of vitamin D, from both food and supplements, was linked to a 42% lower risk of developing…